All In Biotech

Drug Trial Radar · NCT05904028

Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD

Last checked: Nov 20, 2026Latest source record: Jul 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 603 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

603

Actual

Start

Nov 9, 2023

Primary completion

Jul 30, 2027

Study completion Jul 30, 2027

Sponsor

Lead sponsor
Jaeb Center for Health ResearchAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institutes of Health (NIH); National Eye Institute (NEI); Juvenile Diabetes Research Foundation
First posted
Jun 15, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Home optical coherence tomography- guided treatment versus treat and extend for the management of neovascular age-related macular degeneration.

Conditions

  • Neovascular Age-related Macular Degeneration

Interventions

  • Intravitreal injections of 6 mg faricimab on a Treat and Extend scheduleDrug

    Intravitreal injections of 6 mg faricimab on a Treat and Extend schedule

  • Intravitreal injections of 6 mg faricimab on a home optical coherence tomography-guided treatment scheduleDevice

    Intravitreal injections of 6 mg faricimab on a Home OCT-guided treatment schedule

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. E-ETDRS Change in Visual Acuity Letter ScoreTime frame: Baseline to 104 weeks
  2. Number of intravitreal injections of Faricimab (6.0 mg) in the study eyeTime frame: Baseline to 104 weeks

Locations

64 sites in 2 countries. Site status is shown where the registry gives one.

  • Kent W. Small, MD, AMC

    Glendale, California

  • Loma Linda University

    Loma Linda, California

  • East Bay Retina Consultants, Inc.

    Oakland, California

  • Kaiser Permanente - Oakland

    Oakland, California

  • Southern California Desert Retina Consultants, Inc.

    Palm Desert, California

  • UC Davis Health Eye Center

    Sacramento, California

  • Macula Retina Vitreous Institute

    Torrance, California

  • Bay Area Retina Associates A Medical Group

    Walnut Creek, California

  • Retina Consultants

    Manchester, Connecticut

  • National Ophthalmic Research Institute

    Fort Myers, Florida

  • University of Florida- Jacksonville

    Jacksonville, Florida

  • Florida Retina Institute, James A. Staman, MD, PA- Jacksonville

    Jacksonville, Florida

  • Argus Research Center, Inc

    Naples, Florida

  • Southeast Eye Institute, P.A. dba Eye Associates of Pinellas

    Pinellas Park, Florida

  • Retina Associates of Sarasota

    Sarasota, Florida

  • Sarasota Retina Institute

    Sarasota, Florida

  • Retina Associates of Florida, LLC

    Tampa, Florida

  • Southeast Retina Center, P.C.

    Augusta, Georgia

  • Thomas Eye Group

    Sandy Springs, Georgia

  • Northwestern Memorial Group

    Chicago, Illinois

  • Rush University Medical Center

    Chicago, Illinois

  • UIC - Dept of Ophthalmology & Visual Sciences

    Chicago, Illinois

  • The Trustees of Indiana University

    Indianapolis, Indiana

  • Midwest Eye Institute

    Indianapolis, Indiana

  • Wolfe Clinic, P.C.- West Des Moines

    West Des Moines, Iowa

  • Mid-America Retina Consultants, P.A.

    Overland Park, Kansas

  • University of Kentucky Advanced Eye Care

    Lexington, Kentucky

  • Elman Retina Group, BA

    Baltimore, Maryland

  • Johns Hopkins University

    Baltimore, Maryland

  • Valley Eye Physicians and Surgeons

    Ayer, Massachusetts

  • Joslin Diabetes Center

    Boston, Massachusetts

  • Henry Ford Health System

    Detroit, Michigan

  • Retina Associates of Michigan

    Grand Blanc, Michigan

  • Associated Retinal Consultants, P.C.

    Royal Oak, Michigan

  • Associated Retinal Consultants

    Traverse City, Michigan

  • The Retina Institute

    St Louis, Missouri

  • Associated Retinal Surgeons d/b/a Mid Atlantic Retina

    Cherry Hill, New Jersey

  • New York University Langone Health

    New York, New York

  • Macula Care

    New York, New York

  • Vitreous Retina Macula Consultants of NY - VRMNY

    New York, New York

Showing 40 of 64 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.